Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update

QR Code

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update

Robert G MosesClinical Trials and Research Unit, South East Sydney and Illawarra Area Health Service, New South Wales, AustraliaAbstract: Type 2 diabetes is a progressive disease associated with high levels of morbidity and mortality and for which there is both a large and growing prevalence worldwi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Moses R
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	type 2 diabetes metformin repaglinide PrandiMet® fixed-dose combination Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/f258fc99a07a408ba0b23c9f089a972e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
par: Xie J, et autres
Publié: (2019)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
par: Robert G Moses
Publié: (2010)

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
par: Kuecker CM, et autres
Publié: (2016)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
par: Robert Moses
Publié: (2009)

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
par: Schwartz SS, et autres
Publié: (2016)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
par: Lerner SF, et autres
Publié: (2019)

The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug
par: Yaghoobian M, et autres
Publié: (2020)

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
par: Navarro J, et autres
Publié: (2016)

Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic
par: Dénes Csonka, et autres
Publié: (2021)

Clinical and pharmacological approaches to the choice of a drug for a tension-type headache relief
par: Evgeniya V. Shikh, et autres
Publié: (2021)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
par: Zhang Q, et autres
Publié: (2020)

Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus
par: Jevtovic F
Publié: (2021)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
par: Jonathan K Reynolds
Publié: (2009)

Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study
par: Iribhogbe OI, et autres
Publié: (2017)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
par: Tangjarusritaratorn T, et autres
Publié: (2021)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
par: Gebrie D, et autres
Publié: (2021)

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
par: Fleming JW, et autres
Publié: (2015)

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
par: Hassoun AAK, et autres
Publié: (2016)

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
par: Green J, et autres
Publié: (2010)

A Comparison Between the Therapeutic Effect of Metformin Alone versus a Combination Therapy with Insulin in Uncontrolled, Non-Adherence Patients with Type 2 Diabetes: Six Months Follow-Up
par: Paczkowska A, et autres
Publié: (2021)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
par: Wang N, et autres
Publié: (2020)

Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats
par: Figueiredo ID, et autres
Publié: (2020)

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler<sup>®</sup> Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
par: Paschalis Steiropoulos, et autres
Publié: (2021)

Combine therapy as a modern approach to treatment of allergic rhinitis
par: Alexander V. Emelyanov
Publié: (2021)

Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
par: Leng W, et autres
Publié: (2021)

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
par: Maffioli P, et autres
Publié: (2011)

Metformin and Malignant Tumors: Not Over the Hill
par: Leng W, et autres
Publié: (2021)

Dissolution Profile Evaluation of Eight Brands of Metformin Hydrochloride Tablets Available in Jimma, Southwest Ethiopia
par: Umeta B, et autres
Publié: (2021)

Assessment of Serum Vitamin B12 and Folate Levels and Macrocytosis in Patients with Type 2 Diabetes Mellitus on Metformin Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study
par: Wale Tesega W, et autres
Publié: (2021)

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
par: Zhang F, et autres
Publié: (2021)

Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study
par: Osonoi T, et autres
Publié: (2020)

Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
par: Albai O, et autres
Publié: (2020)

Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
par: Pingali U, et autres
Publié: (2020)

Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
par: Yu H, et autres
Publié: (2017)

Bayesian Design for Identifying Cohort-Specific Optimal Dose Combinations Based on Multiple Endpoints: Application to a Phase I Trial in Non-Small Cell Lung Cancer
par: Bethany Jablonski Horton, et autres
Publié: (2021)

Clinical utility of fixed combinations of sitagliptin&ndash;metformin in treatment of type 2 diabetes
par: Karen Barnard, et autres
Publié: (2010)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
par: Natalya Vladislavovna Zaytseva, et autres
Publié: (2015)

Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents
par: Han J, et autres
Publié: (2018)

Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes
par: Schweighofer N, et autres
Publié: (2020)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
par: Kunavisarut T, et autres
Publié: (2019)